user

Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010–2011 influenza season

被引：0
|
作者：
Patrick A. Dhont
Adelin Albert
Patrick Brenders
Anna Podwapinska
Ann Pollet
Dirk Scheveneels
François Tihon
Ilse Verheyden
Jan Victor
Sandrine I. Samson
机构：
[1] Sanofi Pasteur MSD,Department of Biostatistics
[2] University of Liège,undefined
[3] CHU Sart Tilman,undefined
[4] Sanofi Pasteur MSD,undefined
来源：
Advances in Therapy | 2012年 / 29卷
关键词：
Belgium; Elderly individuals; General practitioners; Immunosenescence; Intanza; Intradermal influenza vaccine; Micro-needle injection system; Survey; Vaccination acceptability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：562 / 577
页数：15
相关论文
共 50 条
  • [1] Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010-2011 influenza season
    Dhont, Patrick A.
    Albert, Adelin
    Brenders, Patrick
    Podwapinska, Anna
    Pollet, Ann
    Scheveneels, Dirk
    Tihon, Francois
    Verheyden, Ilse
    Victor, Jan
    Samson, Sandrine I.
    ADVANCES IN THERAPY, 2012, 29 (06) : 562 - 577
  • [2] Intanza®: a new intradermal vaccine for seasonal influenza
    Atmar, Robert L.
    Patel, Shital M.
    Keitel, Wendy A.
    EXPERT REVIEW OF VACCINES, 2010, 9 (12) : 1399 - 1409
  • [3] Intanza® 15 μg Intradermal Seasonal Influenza Vaccine In Older Adults (Aged ≥60 Years)
    Duggan, Sean T.
    Plosker, Greg L.
    DRUGS & AGING, 2010, 27 (07) : 597 - 605
  • [4] Intanza® 15 μg Intradermal Seasonal Influenza Vaccine in Older Adults (Aged ≥60 Years)Profile Report
    Sean T. Duggan
    Greg L. Plosker
    BioDrugs, 2010, 24 : 407 - 409
  • [5] Intanza® 15 μg Intradermal Seasonal Influenza Vaccine in Older Adults (Aged ≥60 Years) Profile Report
    Duggan, Sean T.
    Plosker, Greg L.
    BIODRUGS, 2010, 24 (06) : 407 - 409
  • [6] Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina
    Peter Eizenberg
    Robert Booy
    Nadim Naser
    Glen Mason
    Daniel Stamboulian
    Françoise Weber
    Advances in Therapy, 2011, 28 : 640 - 649
  • [7] Intanza® 9 μg intradermal seasonal influenza vaccine for adults 18 to 59 years of age
    Leroux-Roels, Isabel
    Weber, Francoise
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (01) : 115 - 121
  • [8] Intanza® 15 µg Intradermal Seasonal Influenza VaccineIn Older Adults (Aged ≥60 Years)
    Sean T. Duggan
    Greg L. Plosker
    Drugs & Aging, 2010, 27 : 597 - 605
  • [9] Immunogenicity and safety of Intanza®/IDflu® intradermal influenza vaccine in South Korean adults
    Han, Sang Hoon
    Woo, Jun Hee
    Weber, Francoise
    Kim, Woo Joo
    Peck, Kyong Ran
    Kim, Sang Il
    Choi, Young Hwa
    Kim, June Myung
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (09) : 1971 - 1977
  • [10] Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey
    Prymula, Roman
    Usluer, Gaye
    Altinel, Serdar
    Sichova, Radka
    Weber, Francoise
    ADVANCES IN THERAPY, 2012, 29 (01) : 41 - 52
12345